The Female Health Company to Present at Rodman & Renshaw's Annual Global
Investment Conference on Tuesday, September 13, 2011
CHICAGO, Sept. 1, 2011 /PRNewswire via COMTEX/ -- The Female Health Company
(nasdaq-cm:FHCO), which manufactures and markets the FC2 Female Condom?, today
announced that the Company's CEO, O.B. Parrish, and its CFO, Donna Felch, are
scheduled to make a presentation at Rodman & Renshaw's Global Investment
Conference at 4:05 p.m. on Tuesday, September 13, 2011, in the Empire Room (lobby
level).
The Conference will be held September 11-13, 2011 at the New York Waldorf-Astoria
in New York City. Additional information on the Conference is available on the
Internet at rodmanandrenshaw.com.
About Rodman & Renshaw
Rodman & Renshaw is a full-service investment banking firm that is dedicated to
providing investment banking services to companies that have significant
recurring capital needs due to their growth and development strategies. The firm
also provides research, sales and trading services to institutional investor
clients that focus on such companies.
Through its life sciences investment banking team, Rodman & Renshaw provides a
broad range of investment banking services to biotechnology, specialty
pharmaceutical, medical device and other companies operating in the life science
space. The team consists of seasoned professionals, many of whom have PhDs or
other advanced medical or scientific degrees. Their experience and expertise
enable the firm to deliver the specialized advice and differentiated services its
clients demand. |
